Search Results - Ottmann, Oliver

A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia by Döhner, Hartmut (Author) , Müller-Tidow, Carsten (Author) , Lübbert, Michael (Author) , Fiedler, Walter (Author) , Krämer, Alwin (Author) , Westermann, Jörg (Author) , Bug, Gesine (Author) , Schlenk, Richard Friedrich (Author) , Krug, Utz (Author) , Goeldner, Rainer-Georg (Author) , Hilbert, James (Author) , Taube, Tillmann (Author) , Ottmann, Oliver G. (Author) ,

• Volltext
• Volltext

Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia by Ottmann, Oliver G. (Author) , Krämer, Alwin (Author) , Bochtler, Tilmann (Author) ,

• Volltext
• Volltext

Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials by Schlenk, Richard Friedrich (Author) , Krauter, Jürgen (Author) , Raffoux, Emmanuel (Author) , Kreuzer, Karl-Anton (Author) , Schaich, Markus (Author) , Noens, Lucien (Author) , Pabst, Thomas (Author) , Vusirikala, Madhuri (Author) , Bouscary, Didier (Author) , Spencer, Andrew (Author) , Candoni, Anna (Author) , Gil, Jorge Sierra (Author) , Berkowitz, Noah (Author) , Weber, Hans-Jochen (Author) , Ottmann, Oliver (Author) ,

798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a...

• kostenfrei

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy by Döhner, Hartmut (Author) , Lübbert, Michael (Author) , Fiedler, Walter (Author) , Fouillard, Loic (Author) , Haaland, Alf (Author) , Brandwein, Joseph M. (Author) , Lepretre, Stephane (Author) , Reman, Oumedaly (Author) , Turlure, Pascal (Author) , Ottmann, Oliver G. (Author) , Müller-Tidow, Carsten (Author) , Krämer, Alwin (Author) , Raffoux, Emmanuel (Author) , Döhner, Konstanze (Author) , Schlenk, Richard F. (Author) , Voß, Florian (Author) , Taube, Tillmann (Author) , Fritsche, Holger (Author) , Maertens, Johan (Author) ,

• lizenzpflichtig
• Volltext

A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute my... by Müller-Tidow, Carsten (Author) , Bug, Gesine (Author) , Lübbert, Michael (Author) , Krämer, Alwin (Author) , Krauter, Jürgen (Author) , Valent, Peter (Author) , Nachbaur, David (Author) , Berdel, Wolfgang E. (Author) , Ottmann, Oliver G. (Author) , Fritsch, Holger (Author) , Munzert, Gerd (Author) , Garin-Chesa, Pilar (Author) , Fleischer, Frank (Author) , Taube, Tillmann (Author) , Döhner, Hartmut (Author) ,

• Volltext
• Volltext

Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis by Frühauf, Stefan (Author) , Topaly, Julian (Author) , Buß, Eike Christian (Author) , Fischer, Thomas (Author) , Ottmann, Oliver G. (Author) , Emmerich, Bertold (Author) , Müller, Martin Christian (Author) , Schuld, Peter (Author) , Balleisen, Leopold (Author) , Hehlmann, Rüdiger (Author) , Ho, Anthony Dick (Author) , Hochhaus, Andreas (Author) ,

• lizenzpflichtig
• lizenzpflichtig